{"database": "lobbying", "table": "lobbying_activities", "rows": [[1437744, "8c49cb63-258a-4a25-ac6a-4546565120ce", "Q3", "MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY", 62277, "MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY", 2013, "third_quarter", "MMM", "S. Con. Res. 8 --Concurrent Resolution on the Budget for Fiscal Year 2014\nH. Con. Res. 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY '15 through 2033In all of the above the specific issues include potential Medicare offsets that might be applied to prescription drugs, especially changes to ASP, physician payment and oncology matters.", "HOUSE OF REPRESENTATIVES,SENATE", null, 280000, 0, 0, "2013-10-02T15:50:14.960000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1437744"], "units": {}, "query_ms": 29.734186944551766, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}